|
| 37607324 | Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma. | J Clin Oncol | 2023 |
| 37561583 | Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. | J Clin Invest | 2023 |
| 34949653 | Cancer-Causative Mutations Occurring in Early Embryogenesis. | Cancer Discov | 2022 |
| 35817971 | Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity. | Nat Genet | 2022 |
| 36089134 | APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas. | Ann Oncol | 2022 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |
| 33674143 | Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. | Gynecol Oncol | 2021 |
| 33893322 | Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. | NPJ Breast Cancer | 2021 |
| 33834176 | Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. | Nat Cancer | 2021 |
| 32444418 | Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. | Clin Cancer Res | 2020 |
| 33066781 | Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference? | Radiat Oncol | 2020 |
| 30415991 | Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. | Gynecol Oncol | 2019 |
| 32914019 | Endometrial Cancers in <i>BRCA1</i> or <i>BRCA2</i> Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects. | JCO Precis Oncol | 2019 |
| 31360805 | Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data. | Adv Radiat Oncol | 2019 |
| 31360903 | The Landscape of Somatic Genetic Alterations in Breast Cancers from <i>CHEK2</i> Germline Mutation Carriers. | JNCI Cancer Spectr | 2019 |
| 30741847 | Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer. | J Urol | 2019 |
| 29254782 | Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients. | Int J Radiat Oncol Biol Phys | 2018 |
| 29976496 | Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation. | Int J Radiat Oncol Biol Phys | 2018 |
| 27523595 | Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. | Eur Urol | 2017 |
| 28464446 | Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer. | BJU Int | 2017 |
| 28390657 | Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5ÿ6Gy) conformal radiotherapy. | Radiother Oncol | 2017 |
| 28838648 | Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time. | Brachytherapy | 2017 |
| 28542679 | Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques. | JAMA Oncol | 2017 |
| 27009848 | Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy. | Brachytherapy | 2016 |
| 26476405 | Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer. | Urology | 2016 |
| 27756494 | Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental? | Radiother Oncol | 2016 |
| 26780999 | Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. | Radiother Oncol | 2016 |
| 26936027 | Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. | Lancet Oncol | 2016 |
| 25327412 | Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy. | Prostate | 2015 |
| 26165583 | Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer. | J Urol | 2015 |
| 25820537 | Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. | Eur Radiol | 2015 |
| 25500364 | Statin use not associated with improved outcomes in patients treated with brachytherapy for prostate cancer. | Brachytherapy | 2015 |
| 25564167 | The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy. | Ann Surg Oncol | 2015 |
| 25345838 | Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity. | BJU Int | 2015 |
| 25308970 | The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. | Eur Urol | 2015 |
| 24447404 | Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer. | BJU Int | 2014 |
| 24603102 | Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer. | J Urol | 2014 |
| 24373762 | A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. | Brachytherapy | 2014 |
| 22831750 | Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer. | Brachytherapy | 2013 |
| 23551568 | Favourable long-term outcomes with brachytherapy-based regimens in men ⿤60 years with clinically localized prostate cancer. | BJU Int | 2013 |
| 23523323 | Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes. | Int J Radiat Oncol Biol Phys | 2013 |
| 23273878 | Regulation of microtubule stability and organization by mammalian Par3 in specifying neuronal polarity. | Dev Cell | 2013 |
| 23182392 | Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis. | Int J Radiat Oncol Biol Phys | 2013 |
| 23287698 | Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. | Eur Urol | 2013 |
| 22981709 | Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy. | Int J Radiat Oncol Biol Phys | 2013 |
| 22795805 | Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. | Int J Radiat Oncol Biol Phys | 2013 |
| 21596489 | Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. | Int J Radiat Oncol Biol Phys | 2012 |
| 22889401 | Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. | BJU Int | 2012 |
| 22300563 | Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. | Int J Radiat Oncol Biol Phys | 2012 |
| 22330997 | Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. | Int J Radiat Oncol Biol Phys | 2012 |